Tumor-derived exosomes: a new source of tumor rejection antigens-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor-derived exosomes: a new source of tumor rejection antigens

Published:2002-12 Issue: Volume:20 Page:A28-A31
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

André F,Schartz N.E.C,Chaput N,Flament C,Raposo G,Amigorena S,Angevin E,Zitvogel L

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference23 articles.

1. IFN-gamma and lymphocytes prevent primary tumor development and shape tumor immunogenicity;Shankaran;Nature,2001

2. A gene encoding an antigen recognized by cytolytic T-lymphocytes on a human melanoma;Van der Bruggen;Science,1991

3. Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group;Sondak;J. Clin. Oncol.,2002

4. Christian D, Axel R, Walter L, Dieter J. Multicenter phase III trial to compare radical nephrectomy plus adjuvant autologous tumor cell-lysate vaccine versus radical nephrectomy without adjuvant treatment for renal cell carcinoma stages pT2-3bpN0-3M0: a 3-year analysis. Proc. Am. Soc. Clin. Oncol. 2002;A717.

5. Active-specific immunotherapy for stage II and stage III human colon cancer: a randomised trial;Vermorken;Lancet,1999

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

2. New uses of halofuginone to treat cancer;Journal of Pharmaceutical Analysis;2024-08

3. Empowering Exosomes with Aptamers for Precision Theranostics;Small Methods;2024-07-05

4. Exosome-based anticancer vaccines: From Bench to bedside;Cancer Letters;2024-07

5. 2D/0D Heterojunction Interface with Photovoltaic Enhancement and Stabilization for Label‐Free Exosome Biosensor;Advanced Functional Materials;2024-05-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3